|
NAV2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82676096471823E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.80695475143966E-13 |
| Normal-vs-Stage2 |
1.613650E-02 |
| Normal-vs-Stage3 |
1.80500000002137E-06 |
| Normal-vs-Stage4 |
6.814000E-04 |
| Stage1-vs-Stage2 |
1.508780E-01 |
| Stage1-vs-Stage3 |
2.946800E-01 |
| Stage1-vs-Stage4 |
2.421700E-02 |
| Stage2-vs-Stage3 |
5.144400E-01 |
| Stage2-vs-Stage4 |
8.982600E-01 |
| Stage3-vs-Stage4 |
3.052600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.72439840184779E-12 |
| Normal-vs-AfricanAmerican |
5.918600E-03 |
| Normal-vs-Asian |
2.181400E-04 |
| Caucasian-vs-AfricanAmerican |
6.730800E-01 |
| Caucasian-vs-Asian |
1.982230E-01 |
| AfricanAmerican-vs-Asian |
7.153000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.89839999778607E-08 |
| Normal-vs-Female |
2.56816790056291E-12 |
| Male-vs-Female |
1.911640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.94764213037979E-12 |
| Normal-vs-Age(41-60Yrs) |
6.21519946619742E-10 |
| Normal-vs-Age(61-80Yrs) |
3.698500E-03 |
| Normal-vs-Age(81-100Yrs) |
4.334400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.958200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.495900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.719500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.088300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.215100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.134600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.800230E-02 |
| Classical-VS-Follicular |
9.53159999816933E-08 |
| Classical-VS-Other |
4.127800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.047750E-01 |
| Tall-VS-Other |
9.860400E-01 |
| Tall-VS-Normal |
9.029700E-04 |
| Follicular-VS-Other |
3.976200E-01 |
| Follicular-VS-Normal |
9.272100E-02 |
| Other-VS-Normal |
1.512360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.81309999925628E-08 |
| Normal-vs-N1 |
1.064930E-03 |
| N0-vs-N1 |
3.462800E-01 |
|
|
